Connect with us
BALAXI

BALAXI PHARMACEUTICALS LIMITED (BALAXI) Stock Analysis

BALAXI PHARMACEUTICALS LIMITED is an Indian pharmaceutical company manufacturing formulations and healthcare products. It markets medicines in domestic and international generic markets. The company operates manufacturing facilities in India. It is a listed small-cap pharma stock.

Healthcare › Drug Manufacturers - Specialty & Generic
₹23.40
+6.74% 1W  |  -41.80% 52W
Market Cap
129 CR
P/E Ratio
52.1
52W High
₹41
52W Low
₹15.2
Div. Yield
0%
Beta
0.8
50 DMA
₹22.3
200 DMA
₹23
Profit Margin
0.9%
Inst. Own.
0%
Trendline Analysis
🚀 BREAKOUT₹26.5₹25.1₹23.8₹22.5₹21.118 May24 Jun03 Aug16 Sep13 Nov3.0L
Fundamentals
Profit & Loss
MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales65.9654.7260.7959.8365.6277.3873.2976.2770.7456.1872.5470.7180.68
YoY Sales growth-20.32%-36.65%-29.79%-25.84%-0.52%+41.41%+20.56%+27.48%+7.80%-27.40%-1.02%-7.29%+14.05%
Expenses57.1243.9647.1446.3655.5366.7969.3063.7266.5855.0269.4570.5976.02
Operating Profit8.8410.7613.6513.4710.0910.593.9912.554.161.163.090.124.66
OPM %13.40%19.66%22.45%22.51%15.38%13.69%5.44%16.45%5.88%2.06%4.26%0.17%5.78%
Other Income-47.685.931.51-0.70-1.85-4.113.94-1.69-1.781.590.102.92-0.99
Interest0.290.370.410.610.370.451.380.741.010.891.020.990.73
Depreciation0.290.660.480.670.490.460.480.460.460.480.560.650.85
Profit before tax-39.4215.6614.2711.497.385.576.079.660.911.381.611.402.09
Tax %4.90%7.92%4.77%4.87%12.06%17.41%11.70%10.56%67.03%84.06%80.75%56.43%38.28%
Net Profit-41.3414.4313.5910.936.484.595.368.640.290.210.310.611.30
EPS in Rs-8.072.822.652.011.170.830.971.570.050.040.060.110.24
Growth — CAGR
Metric3Y5Y10Y
Revenue CAGR-7.0%3.0%–
Profit CAGR-69.0%-48.0%–
Shareholding Pattern
Promoters65.99%
DIIs2.56%
Public31.45%
BALAXI
Holdings Analysis
Key strengths & risk signals
52
Overall
46
Fundamental
58
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
POOR YEAR! Stock declined 41.8% in the last year.
BEARISH TREND! 50-day average (22.3) is below 200-day average (23.0) - negative signal.
LOWER HALF! Trading at 31.8% of 52W range - weakness visible.
Strengths (4)
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
BREAKOUT! Stock has broken above resistance levels with momentum.
STRONG POSITION! Current price (23.4) is above both moving averages.
BELOW MARKET! Beta of 0.80 - slightly less volatile than market.
Fundamental & Technical Analysis
52Overall
46Fundamental
58Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -7.1% (DECLINING, 2/15). Profit CAGR: -68.6% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 0.9% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 10.18% public ownership - strong promoter/institutional control.
Stability Index
6/10
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (22.3) is below 200-day average (23.0) - negative signal.
Price Position
8/10
STRONG POSITION! Current price (23.4) is above both moving averages.
Trend Pattern
20/20
BREAKOUT! Stock has broken above resistance levels with momentum.
52W Performance
0/10
POOR YEAR! Stock declined 41.8% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 23,644 vs down days: 24,470. Ratio: 0.97x
RSI
3/5
NEUTRAL! RSI at 57.7 - balanced momentum.
52W Range
2/5
LOWER HALF! Trading at 31.8% of 52W range - weakness visible.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 6.7% (1 week), 5.7% (1 month), -2.3% (3 months).
Beta
4/5
BELOW MARKET! Beta of 0.80 - slightly less volatile than market.

Peer Comparison

Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
Industry peers
StockPriceP/EProfit MarginRevenue CAGR 5YProfit CAGR 5Y52W ChangeStock StrengthTrendlineYoY ProfitQoQ ProfitYoY RevenueQoQ Revenue
BALAXI₹23.4052.10.9%-7.1%-68.6%-41.8%52 BREAKOUT+333.3%+116.7%+14.1%+14.1%
KREBSBIO₹59.20–-49.7%-23.1%–-13.3%54 CONSOLIDATION-11.5%+116.0%+38.1%-17.1%
ALPA₹56.0033.33.8%4.3%6.1%-32.7%46 CONSOLIDATING DOWN-91.5%-28.6%+25.1%-23.9%
BALPHARMA₹90.90202.2%0.1%34.7%+5.0%66 CONSOLIDATING DOWN+450.0%-69.4%+34.4%+5.4%
PAR₹119.0011.312.1%2.6%5.0%+19.7%57 BREAKDOWN-36.6%+188.9%-4.5%+39.8%
MEDICO₹18.40115.8%11.0%38.0%-64.4%55 BREAKDOWN-8.5%-4.8%+40.6%+6.6%
NATCAPSUQ₹152.10–-8.1%3.6%–-28.6%42 CONSOLIDATING UP+1.8%+14.0%+7.7%-16.8%
VAISHALI₹7.10–4.1%18.0%-15.2%-26.9%49 BREAKDOWN–+278.0%–-15.0%
Data from TradeAlone · Updated daily